| Cover | Sep. 04, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Document Period End Date | Sep. 04, 2024 |
| Entity Registrant Name | Context Therapeutics Inc. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-40654 |
| Entity Tax Identification Number | 86-3738787 |
| Entity Address, Address Line One | 2001 Market Street, |
| Entity Address, Address Line Two | Suite 3915 |
| Entity Address, Address Line Three | Unit #15 |
| Entity Address, City or Town | Philadelphia |
| Entity Address, State or Province | PA |
| Entity Address, Postal Zip Code | 19103 |
| City Area Code | (267) |
| Local Phone Number | 225-7416 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock |
| Trading Symbol | CNTX |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
| Entity Central Index Key | 0001842952 |
| Amendment Flag | false |
